References
- Rawson JS, Achord JL. Shock liver. South Med J. 1985;78(12):1421–1425.
- Killip T, Payne MA. High serum transaminase activity in heart disease. Circulatory failure and hepatic necrosis. Circulation. 1960;21(May):646–660.
- Ellenberg M, Osserman KE. The role of shock in the production of central liver cell necrosis. Am J Med. 1951;11(2):170–178.
- Birgens HS, Henriksen J, Matzen P, et al. The shock liver. Clinical and biochemical findings in patients with centrilobular liver necrosis following cardiogenic shock. Acta Med Scand. 1978;204(5):417–421.
- Arcidi JM, Moore GW, Hutchins GM. Hepatic morphology in cardiac dysfunction. A clinicopathologic study of 1000 subjects at autopsy. Am J Pathol. 1981;104(2):159–166.
- Bynum TE, Boitnott JK, Maddrey WC. Ischemic hepatitis. Dig Dis Sci. 1979;24(2):129–135.
- Seeto RK, Fenn B, Rockey DC. Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med. 2000;109(2):109–113.
- Waseem N, Chen PH. Hypoxic hepatitis: a review and clinical update. J Clin Transl Hepatol. 2016;4(3):263–268.
- Birrer R, Takuda Y, Takara T. Hypoxic hepatopathy: pathophysiology and prognosis. Intern Med. 2007;46(14):1063–1070.
- Henrion J, Schapira M, Luwaert R, et al. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine. 2003;82(6):392–406.
- Tapper EB, Sengupta N, Bonder A. The incidence and outcomes of ischemic hepatitis: a systematic review with meta-analysis. Am J Med. 2015;128(12):1314–1321.
- Raurich JM, Llompart-Pou JA, Ferreruela M, et al. Hypoxic hepatitis in critically ill patients: incidence, etiology and risk factors for mortality. J Anesth. 2011;25(1):50–56.
- Jentzer JC, van Diepen S, Henry TD. Understanding how cardiac arrest complicates the analysis of clinical trials of cardiogenic shock. Circ Cardiovasc Qual Outcomes. 2020;13(9):e006692.
- Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179–c184.
- Weibrecht K, Dayno M, Darling C, et al. Liver aminotransferases are elevated with rhabdomyolysis in the absence of significant liver injury. J Med Toxicol. 2010;6(3):294–300.
- Nathwani RA, Pais S, Reynolds TB, et al. Serum alanine aminotransferase in skeletal muscle diseases. Hepatology. 2005;41(2):380–382.
- Johnson CD. UK guidelines for the management of acute pancreatitis. Gut. 2005;54(Suppl. 3):1–9.
- Aboelsoud MM, Javaid AI, Al-Qadi MO, et al. Hypoxic hepatitis – its biochemical profile, causes and risk factors of mortality in critically-ill patients: a cohort study of 565 patients. J Crit Care. 2017;41:9–15.
- Henrion J. Hypoxic hepatitis. Liver Int. 2012;32(7):1039–1052.
- Gibson PR, Dudley FJ. Ischemic hepatitis: clinical features, diagnosis and prognosis. Aust NZ J Med. 1984;14(6):822–825.
- Björnsson HK, Olafsson S, Bergmann OM, et al. A prospective study on the causes of notably raised alanine aminotransferase (ALT). Scand J Gastroenterol. 2016;51(5):594–600.
- Fuhrmann V, Kneidinger N, Herkner H, et al. Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med. 2009;35(8):1397–1405.
- Lightsey JM, Rockey DC. Current concepts in ischemic hepatitis. Curr Opin Gastroenterol. 2017;33(3):158–163.
- Drolz A, Horvatits T, Roedl K, et al. Outcome and features of acute kidney injury complicating hypoxic hepatitis at the medical intensive care unit. Ann Intensive Care. 2016;6:61.
- Chávez-Tapia NC, Balderas-Garces BV, Meza-Meneses P, et al. Hypoxic hepatitis in cardiac intensive care unit: a study of cardiovascular risk factors, clinical course, and outcomes. Ther Clin Risk Manag. 2014;10:139–145.
- Chang P-E, Goh B-BG, Ekstrom V, et al. Low serum albumin predicts early mortality in patients with severe hypoxic hepatitis retrospective study. World J Hepatol. 2017;9(22):959–966.
- Roedl K, Spiel A, Nürnberger A, et al. Hypoxic liver injury after in- and out-of-hospital cardiac arrest: risk factors and neurological outcome. Resuscitation. 2019;137:175–182.
- Ferreira M, Coelho R, Luzio J, et al. Increased lipase and amilase levels in critically ill patients: retrospective study. Rev Bras Ter Intensiva. 2008;20(4):362–369.
- Fuhrmann V, Kneidinger N, Herkner H, et al. Impact of hypoxic hepatitis on mortality in the intensive care unit. Intensive Care Med. 2011;37(8):1302–1310.
- Jäger B, Drolz A, Michl B, et al. Jaundice increases the rate of complications and one-year mortality in patients with hypoxic hepatitis. Hepatology. 2012;56(6):2297–2304.